News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016
SoCal's Puma Biotech (PBYI) Delays NDA for Neratinib to Treat Breast Cancer Until Mid-2016     3/29/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Breast Cancer Pipeline Has More than 1,000 Drugs in Development     3/9/2016
Immunomedics (IMMU)'s Breast Cancer Drug Wins Breakthrough Tag from the FDA     2/5/2016
NanoString (NSTG) Touts Collaborative Work in Immuno-Oncology at J.P. Morgan Conference     1/11/2016
Investors Await Four Key FDA Decisions in the First Quarter of 2016     1/5/2016

News from Around the Web
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016
Hops Extract Could Help Reduce Breast Cancer Risk, University of Illinois Study     7/12/2016
Why Do More Black Women Die of Breast Cancer? NIH Study     7/8/2016
NASA Technology Reveals Bacteria's Role In Breast Cancer     6/28/2016
In Mice, Daughters Of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk, Georgetown University Medical Center Study     6/27/2016
4 Things You Can Do To Decrease The Chance Your Breast Cancer Risk, Study Published In JAMA     6/3/2016
Breast Cancer Drug Found To Reduce Seizures, Northwestern University Study     5/24/2016
Eating Fatty Foods When Young May Up Your Breast Cancer Risk, University of Maryland Study     5/23/2016
Samsung Corporation Applies Deep Learning To Ultrasound Device     4/21/2016
ANGLE Device Able To Track Spread Of Breast Cancer, University of Southern California Study     4/20/2016
A Simple Diagnostic Blood Test For Breast Cancer, Macquarie University Reveals     3/24/2016

Press Releases
Peregrine (PPHM) Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance The Anti-Tumor Activity Of Multiple Checkpoint Targeting Agents In Model Of Triple Negative Breast Cancer (TNBC)     9/27/2016
Daiichi Sankyo To Present At ESMO 2016 Late-Breaking Clinical Data For Novel HER2-Targeting Antibody Drug Conjugate In T-DM1 Pre-Treated Breast Cancer     9/27/2016
First Patient Enrolled In Toca 6, Tocagen's Trial For Metastatic Cancers Evaluating Intravenously Delivered Toca 511 Virus     9/22/2016
Puma Biotech (PBYI) Announces FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer     9/20/2016
Abilita Bio Awarded NCI Phase-I SBIR Grant To Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer     9/20/2016
Two New Studies Demonstrate Advantages Of Andrew Technologies, Inc.’ Hydrasolve As The Company Heads To ASPS 2016     9/19/2016
Pfizer (PFE) Receives Positive CHMP Opinion For IBRANCE (Palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe     9/16/2016
Navidea (NAVB)’s Lymphoseek Receives Positive Opinion In Europe For A New Reduced Mass Vial     9/16/2016
Ambry Genetics Donates $125,000 In Breast Cancer Genetic Testing Vouchers To Mauli Ola Foundation     9/16/2016
GTx, Inc. (GTXI) Achieves Stage 1 Milestone In Phase II Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer     9/8/2016
Avelas Biosciences Completes Patient Enrollment For AVB-620 Phase 1b Clinical Trial     9/8/2016
Cascadian Therapeutics (ONTY) Announces Approval Of Nonproprietary Name “Tucatinib” For Lead Product Candidate ONT-380     9/1/2016
Gradalis Inc. Announces Dosing Of First Patient In Pilot Study Combining Vigil Engineered Autologous Tumor Cell Immunotherapy And Durvalumab In Advanced Breast Cancer     8/29/2016
ImmunoPhotonics Announces First Patient Dosed In A Randomized, Controlled Breast Cancer Clinical Trial For Incvax – A Novel Investigational Immuno-Oncology Therapy     8/23/2016
Puma Biotech (PBYI) Announces EMA Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe     8/22/2016

//-->